Analyst Price Targets — CAH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 19, 2026 7:06 am | Ryan Halsted | RBC Capital | $276.00 | $234.98 | StreetInsider | RBC Capital Starts Cardinal Health (CAH) at Outperform |
| August 13, 2026 9:17 am | — | Barclays | $275.00 | $234.16 | TheFly | Cardinal Health price target raised to $275 from $258 at Barclays |
| August 12, 2026 12:23 pm | — | Morgan Stanley | $265.00 | $236.64 | TheFly | Cardinal Health price target raised to $265 from $255 at Morgan Stanley |
| August 12, 2026 11:50 am | — | Evercore ISI | $270.00 | $240.26 | TheFly | Cardinal Health price target raised to $270 from $265 at Evercore ISI |
| August 12, 2026 11:26 am | — | UBS | $280.00 | $240.26 | TheFly | Cardinal Health price target raised to $280 from $274 at UBS |
| August 12, 2026 11:03 am | Stephen Baxter | Wells Fargo | $277.00 | $240.26 | TheFly | Cardinal Health price target raised to $277 from $245 at Wells Fargo |
| August 12, 2026 10:36 am | Steven Valiquette | Mizuho Securities | $250.00 | $240.26 | StreetInsider | Cardinal Health (CAH) PT Raised to $250 at Mizuho |
| August 12, 2026 10:20 am | Eric Coldwell | Robert W. Baird | $274.00 | $240.26 | TheFly | Cardinal Health price target raised to $274 from $251 at Baird |
| August 11, 2026 6:59 pm | — | Leerink Partners | $292.00 | $240.26 | TheFly | Cardinal Health price target raised to $292 from $275 at Leerink |
| July 20, 2026 1:24 pm | — | UBS | $274.00 | $226.42 | TheFly | Cardinal Health price target raised to $274 from $260 at UBS |
Latest News for CAH
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cardinal Health's generic volumes, profitable brand-to-generic conversions and Red Oak program continue to support Pharma profits.
NBIX's Crenessity gains rapid traction in CAH, with sales soaring and low patient penetration leaving room for growth.
Connor Clark and Lunn Investment Management Ltd. bought a new position in shares of Cardinal Health, Inc. (NYSE: CAH) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 3,554 shares of the company's stock, valued at approximately $844,000. Other large investors also
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.